SEC Form 4 reporting owner

Pham Quang X

Pham Quang X has filed 22 Form 4 transactions reported between May 11, 2026 and June 29, 2026, as Chairman and CEO, Chairman, CEO and Interim CFO, CEO and Chairman of Cadrenal Therapeutics, Inc..

Name as filed: Pham Quang X

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$388K
22 lines
Companies
1
with Form 4 filings
Latest transaction
Jun 29, 2026
transaction date

Roles and reported holdings

  • CVKDCadrenal Therapeutics, Inc.
    May 11, 2026 – Jun 29, 2026

    Chairman and CEO, Chairman, CEO and Interim CFO, CEO and Chairman

    Held directly98,589 sh as of Jun 29, 2026 · Form 4

    24 months: $388K sold

Transaction history

All 22 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 29, 2026CVKDChairman and CEOOpen-market saleCode S · direct7,400$22K@ $3.03Form 4
Jun 26, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct9,029$28K@ $3.05Form 4
Jun 25, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct2,127$6K@ $3.00Form 4
Jun 23, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct2,277$7K@ $3.20Form 4
Jun 22, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct9,167$33K@ $3.55Form 4
Jun 17, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct513$2K@ $3.16Form 4
Jun 16, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct3,613$11K@ $3.18Form 4
Jun 15, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct3,666$13K@ $3.58Form 4
Jun 12, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct12,996$51K@ $3.94Form 4
Jun 11, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct1,462$6K@ $4.12Form 4
Jun 10, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct3,500$15K@ $4.21Form 4
Jun 9, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct12,992$53K@ $4.06Form 4
Jun 8, 2026CVKDChairman, CEO and Interim CFOOpen-market saleCode S · direct5,893$26K@ $4.38Form 4
Jun 5, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct2,064$9K@ $4.42Form 4
Jun 4, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct3,898$17K@ $4.41Form 4
Jun 3, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct2,323$10K@ $4.26Form 4
Jun 2, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct349$2K@ $4.46Form 4
May 29, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct303$2K@ $5.01Form 4
May 28, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct2,989$15K@ $4.93Form 4
May 22, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct1,165$7K@ $5.69Form 4
May 12, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct3,298$17K@ $5.28Form 4
May 11, 2026CVKDCEO and ChairmanOpen-market saleCode S · direct6,476$37K@ $5.76Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.